Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Performance of the Novalung Ultimate Kit and Xenios 2.0 During Stationary Use in Hospital and Ground-based Transport of Patients on Extracorporeal Life Support (ECLS)

NCT07156669 is registered in ClinicalTrials.gov with Xenios AG as lead sponsor.

NCT NCT07156669
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07156669 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Performance of the Novalung Ultimate Kit and Xenios 2.0 During Stationary Use in Hospital and Ground-based Transport of Patients on Extracorporeal Life Support (ECLS)
Lead sponsor
Xenios AG
Phase
Observational
Overall status
Recruiting
Start date
May 19, 2026
Completion date
July 31, 2027
Enrollment
20 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute lung injury, cardio-respiratory failure, extracorporeal membrane oxygenation complication